Insider Trading & Ownership - Melincoff Gwen A

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Melincoff Gwen A
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-11-19
Purchase
2019-11-20
5:02 pm
SOLENO THERAPEUTICS INCSLNOMelincoff Gwen A
Director
10,000$1.5364$15,36410,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-24
Option Award
2024-06-26
9:30 pm
N/A
2034-06-24
Gain Therapeutics Inc.GANXMelincoff Gwen A
Director
15,000$015,000
(Direct)
View
2024-05-16
Option Award
2024-05-16
7:23 pm
N/A
N/A
COLLEGIUM PHARMACEUTICAL INCCOLLMelincoff Gwen A
Director
7,693$052,468
(Direct)
View
2023-09-29
Option Award
2023-10-03
5:00 pm
N/A
2033-09-29
Protalix BioTherapeutics Inc.PLXMelincoff Gwen A
Director
61,676$061,676
(Direct)
View
2023-06-23
Option Award
2023-06-26
4:38 pm
N/A
2033-06-23
Gain Therapeutics Inc.GANXMelincoff Gwen A
Director
10,500$010,500
(Direct)
View
2023-05-25
Option Award
2023-05-26
6:30 pm
N/A
2033-05-25
SOLENO THERAPEUTICS INCSLNOMelincoff Gwen A
Director
12,666$012,666
(Direct)
View
2023-05-18
Option Award
2023-05-19
4:38 pm
N/A
N/A
COLLEGIUM PHARMACEUTICAL INCCOLLMelincoff Gwen A
Director
9,792$044,775
(Direct)
View
2022-06-01
Option Award
2022-10-14
6:30 pm
N/A
2032-06-01
SOLENO THERAPEUTICS INCSLNOMelincoff Gwen A
Director
2,666$02,666
(Direct)
View
2022-09-20
Option Award
2022-09-22
4:09 pm
N/A
2032-09-20
Gain Therapeutics Inc.GANXMelincoff Gwen A
Director
10,500$010,500
(Direct)
View
2022-09-07
Option Award
2022-09-09
5:01 pm
N/A
2032-09-07
Protalix BioTherapeutics Inc.PLXMelincoff Gwen A
Director
50,000$050,000
(Direct)
View
2022-05-19
Option Award
2022-05-23
5:42 pm
N/A
N/A
COLLEGIUM PHARMACEUTICAL INCCOLLMelincoff Gwen A
Director
14,035$034,983
(Direct)
View
2021-06-01
Option Award
2021-06-04
4:31 pm
N/A
2021-06-01
SOLENO THERAPEUTICS INCSLNOMelincoff Gwen A
Director
31,862$031,862
(Direct)
View
2021-05-20
Option Award
2021-05-24
5:16 pm
N/A
N/A
COLLEGIUM PHARMACEUTICAL INCCOLLMelincoff Gwen A
Director
9,941$020,948
(Direct)
View

Ownership
2021-03-17
8:54 pm
N/A
2031-01-22
Gain Therapeutics Inc.GANXMelincoff Gwen A
Director
0$010,000
(Direct)
View
2021-01-08
Option Award
2021-01-12
9:20 pm
N/A
2031-01-08
SOLENO THERAPEUTICS INCSLNOMelincoff Gwen A
Director
40,000$081,887
(Direct)
View
2020-05-20
Option Award
2020-05-22
4:21 pm
N/A
2030-05-20
COLLEGIUM PHARMACEUTICAL INCCOLLMelincoff Gwen A
Director
12,142$019,102
(Direct)
View
2020-05-18
Option Award
2020-05-20
5:56 pm
N/A
2030-05-18
SOLENO THERAPEUTICS INCSLNOMelincoff Gwen A
Director
9,530$09,530
(Direct)
View
2020-01-20
Option Award
2020-01-22
5:01 pm
N/A
2030-01-20
Protalix BioTherapeutics Inc.PLXMelincoff Gwen A
Director
40,000$040,000
(Direct)
View